Homo sapiens Protein: SYNJ1 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-1774.7 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | SYNJ1 | ||||||||||||||||||||||
Protein Name | synaptojanin 1 | ||||||||||||||||||||||
Synonyms | INPP5G; PARK20; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000349903 | ||||||||||||||||||||||
InnateDB Gene | IDBG-1770 (SYNJ1) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Inositol 5-phosphatase which has a role in clathrin- mediated endocytosis. | ||||||||||||||||||||||
Subcellular Localization | Cytoplasm {ECO:0000250}. | ||||||||||||||||||||||
Disease Associations | Parkinson disease 20, early-onset (PARK20) [MIM:615530]: An early-onset form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK20 is characterized by young adult-onset of parkinsonism. Additional features may include seizures, cognitive decline, abnormal eye movements, and dystonia. {ECO:0000269PubMed:23804563, ECO:0000269PubMed:23804577}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||
Tissue Specificity | Concentrated at clathrin-coated endocytic intermediates in nerve terminals. Isoform 1 is more enriched than isoform 2 in developing brain as well as non-neuronal cells. Isoform 2 is very abundant in nerve terminals. | ||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 27 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR000300
Inositol polyphosphate-related phosphatase IPR000504 RNA recognition motif domain IPR002013 Synaptojanin, N-terminal IPR005135 Endonuclease/exonuclease/phosphatase IPR015047 Domain of unknown function DUF1866 |
||||||||||||||||||||||
PFAM |
PF00076
PF02383 PF03372 PF14529 PF08952 |
||||||||||||||||||||||
PRINTS | |||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART |
SM00128
SM00360 |
||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | O43426 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-O43426 | ||||||||||||||||||||||
TrEMBL | C9J1Z6 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 8867 | ||||||||||||||||||||||
UniGene | Hs.473632 | ||||||||||||||||||||||
RefSeq | NP_001153774 | ||||||||||||||||||||||
HUGO | HGNC:11503 | ||||||||||||||||||||||
OMIM | 604297 | ||||||||||||||||||||||
CCDS | CCDS54483 | ||||||||||||||||||||||
HPRD | 09182 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AB020717 AF009039 AF009040 AK295706 AP000275 AP000276 AP000277 AP000278 AP000279 BC098395 | ||||||||||||||||||||||
GenPept | AAC51921 AAC51922 AAH98395 BAA74933 BAG58552 | ||||||||||||||||||||||